Functional cognate T cell recognition is mediated via the interaction of a T cell receptor complex with its pMHC ligand. Adams et al. (2011) in this issue of Immunity provide evidence that docking geometry may impact 2D binding and T cell activation.
The ab T cell receptor (TCR) heterodimer is similar to an immunoglobulin Fab fragment in overall quaternary structure and domain conformation, with each subunit consisting of one variable (V) and one constant (C) immunoglobulin (Ig) domain in the extracellular segment (Garcia et al., 1996) . Nevertheless, close inspection reveals several important differences: the ab TCR heterodimer is wider, with a rather flat binding surface reaching out from the membrane to match its pMHC ligand interaction site; it carries a unique 12 amino acid residue insertion in the Cb domain, termed the Cb FG loop, reinforcing the rigid connectivity between Vb and Cb; and it manifests a peculiar asymmetric disposition of Cb relative to Ca to serve as a dynamic CD3εg docking site (Wang et al., 1998) . The arrangement of the squat CD3 heterodimers, CD3εg and CD3εd, lateral to the centrally placed ab heterodimer in a loose confederation of heavily glycosylated ectodomains fixed by interacting transmembrane segments is noteworthy (Kim et al., 2009 ). The CD3z homodimer, which is virtually without an ectodomain, also forms part of the transmembrane bundle. The CD3 components each have cytoplasmic tails containing immunoreceptor tyrosine-based activation motifs (ITAMs) involved in signaling upon pMHC ligation, contrasting with the short ITAM-less a and b cytoplasmic stumps. These elements collectively comprise the TCR complex.
How pMHC ligation of the ab heterodimer initiates signaling via the CD3 components in conjunction with Lck kinaselinked CD4 or CD8 coreceptors is a matter of intense investigation. That thermodynamic or kinetic parameters of pMHC binding only loosely correlate with T cell activation outcome and that there are no discernible ab TCR heterodimer-pMHC structural changes to distinguish agonist from nonagonist pMHC ligands (Ding et al., 1999) has further added to the mystery of this pivotal immune receptor. The TCR holds the secret of self-versus nonself-discrimination essential for protective host immunity in mammals. When TCR function goes awry, autoimmunity or immunodeficiency may follow. Thus, we need to understand all features of this extraordinary receptor of adaptive T cell immunity.
In this issue, Adams et al. (2011) compare a crystal structure of the alloreactive 42F3 TCR ab heterodimer in complex with the QL9 nonamer peptide of 2-oxogluterate dehydrogenase bound to H2-L d (L d ) with that of the 2C TCR ab heterodimer bound to the same pMHC. By using yeast-displayed H2-L d peptide libraries whose peptide sequences were randomized in three different ways in conjunction with 42F3 tetramers and flow cytometry sorting, they recovered peptides presented by L d with TCR binding sequences divergent from QL9 to varying degrees (e.g., 3A1 and QL9 are entirely different peptides, with no single position identical). In contrast, among the nine peptide residues, 4B10 diverged from QL9 at three TCR residues, and 5E8 diverged at three MHC residues. None of these peptides exists in known proteins. 42F3 complexes with each of these pMHC ligands were crystallized and structurally studied. In addition, solutionbinding affinities of recombinant 42F3 with the various pMHCs were determined by surface plasmon resonance (SPR) (3D), as well as 2D binding affinity of 42F3 cellular transfectants and their respective capacities, to produce interleukin-2 (IL-2).
The key new findings are 4-fold. First, 3A1-L d has the highest solution 3D affinity for 42F3 by SPR equilibrium analysis (3.9 mM). Second, if the membrane-bound 42F3 is used for 3A1-L d interaction analysis in which membrane confinement properties are in play, this so-called ''2D'' interaction shows a less-favorable association. This 2D measurement correlates with lack of IL-2 production of 42F3 T cell transfectants stimulated by peptide-pulsed antigen-presenting cells or pMHC oligomers. Third, the TCRpMHC docking geometry of 42F3 to 3A1-L d , the only nonagonist described here, is divergent from the agonist L d complexes (QL9, 4B10, and 5E8) with 42F3, as well as that between 2C and QL9. TCR 42F3 binds diagonally with respect to the peptide in the agonist pMHC complexes, as commonly observed in many other agonist pMHC-TCR complexes, whereas 42F3 aligns more parallel to the peptide in the nonagonist 3A1 complex. It seems that the ''nondiagonal'' docking observed in the crystal structure may not be compatible with the biologically more relevant 2D binding. Fourth, even when there is a similar docking mode among the same TCR bound to the same MHC but loaded with different peptides, the chemistry of interaction is highly diverse. Different TCR-pMHC complexes can be more or less Va or Vb centric in conserved germline contacts. These findings underscore how plasticity of a single TCR in binding ligand can diversify peptide recognition. At the same time, these data make it abundantly clear that there are no simple recognition ''rules'' allowing ab initio prediction of cognate interaction for the highly evolved mammalian T cell immune system. Figure 1 shows (Borg et al., 2007) . iNKT cells may or may not express coreceptors, but, as Adams suggests, interface specificity is engrafted in the TCR V domains in the absence of coreceptor position. Coreceptors themselves do not bind to the ab heterodimer. In the case of CD4, for example, in which the ectodomain structure is known in its entirety, TCR ab and CD4 bind to the same pMHC in a bidentite manner with their membrane-proximal regions splayed apart by R130 Å (Wang et al., 2001) .
A dynamic rather than a static model of TCR ligation and activation may help to explain the exciting current findings. In this regard, several groups have recently provided evidence that physical force applied to TCR components activates T cells (Husson et al., 2011; Kim et al., 2009; Li et al., 2010) . This activation requires that force be applied to the TCR complex tangentially and not perpendicular to the plane of the T cell membrane, showing that the TCR is an anisotropic mechanosensor (i.e., direction matters). These findings were revealed through structural analysis of the binding of CD3ε monoclonal antibodies in conjunction with optical tweezer experiments. More importantly, when specific pMHC-bound beads were approximated to the T cell membrane, triggering of T cell activation occurred only after tangential force application (Kim et al., 2009) . Such forces can be exerted by cognate pMHC on APCs through binding the TCR on an interacting T cell as the T cell moves when performing immune surveillance prior to a stop movement signal. The greater the functional affinity between pMHC signals and TCR ab heterodimer, the greater the pull, potentially. The pull from pMHC most probably causes the Cb FG loop to push on the upper outer lobe of CD3ε. How ectodomain quaternary changes alter the TCR complex transmembrane segments, surrounding membrane lipid and cytoplasmic tail structures to transduce signals from outside to inside the cell, is a future great scientific challenge.
Parenthetically, bivalent or multimeric crosslinking can torque the TCR in a manner similar to a monomeric interaction with physical load applied. Thus, the importance of bivalent interaction in mediating TCR activation may not be due to the requirement for TCR dimerization per se but rather to torque application. In this regard, the angle of interaction between TCR ab heterodimer and pMHC will affect the torque and, hence, physical force placed on the CD3 subunits. Catch bonds may form under load, and these could also change the nature of TCRpMHC interaction.
Lastly, unlike antibody Fabs, the TCR ab and CD3g and CD3d elements are highly N-linked glycosylated. Glycans are dynamic, large, and tunable. Those adducts will affect movement of the TCR subunits and subsequent signaling. A study consistent with this notion shows that TCR functional avidity is altered by removal of a Ca glycan, for example (Kuball et al., 2009) . Given the detailed information available from Adams et al., 42F3 may be an ideal system to explore the effect of these variables on T cell signaling. It now appears that MHC-restricted TCR recognition is ''restricted'' by additional parameters. The structural and functional studies in the current paper serve well to underscore the need for further investigation.
